Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. 1984

M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
October 1985, American journal of clinical oncology,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
October 1986, Cancer treatment reports,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
August 1984, American journal of clinical oncology,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
January 1985, Investigational new drugs,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
January 1980, Cancer treatment reports,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
August 1988, American journal of clinical oncology,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
November 1990, Investigational new drugs,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
May 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
January 1979, Cancer treatment reports,
M Levin, and K J Pandya, and J D Khandekar, and J Horton, and J H Glick, and J M Bennett, and F M Muggia, and G Falkson
January 1983, Investigational new drugs,
Copied contents to your clipboard!